Neonatal Respiratory Distress Syndrome
16
2
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
2 terminated out of 16 trials
81.8%
-4.7% vs benchmark
0%
0 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
MINImising Total Radiation EXposure in Preterm Infants
To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation
Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS
Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year
Breathing Variability and NAVA in Neonates
A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)
Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants
Impact of Neurophysiological Facilitation of Respiration in Preterm Neonates
Effect of Antenatal Corticosteroids on Neonatal Morbidity.
Breastfeeding Infants Receiving Respiratory Support Trial
The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome
Flow-cycled Ventilation in Preterm Infants
Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome
Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation
Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome